This prescription-based tablet formulation, as detailed in image_0b3181.png, contains the active ingredients Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP (500 mg + 1 mg). Available in a 10 x 15 tablet pack size, it is professionally intended for prescription-based diabetes management as advised by a doctor. The product is highly suitable for anti-diabetic product listings targeted toward clinics, pharmacies, hospitals, and commercial distributors. Patients must use this medication only as directed by a registered healthcare professional, taking it precisely at the prescribed time and dose without stopping, repeating, or altering the dosage without medical advice. Finally, it must be administered strictly under medical supervision with blood sugar monitored as advised, ensuring it is kept completely out of reach of children and that all label and batch configurations are properly verified before dispensing.